Atlas Trials

Addition of Azithromycin to Cefazolin Will Reduce Post CS Infections More Than Cefazolin Only.

Clinical trial NCT03502356 · UNKNOWN

Trial details

NCT number
NCT03502356
Sponsor
Ain Shams University
Status
UNKNOWN
Phase
Phase 1, Phase 2
Study type
INTERVENTIONAL
Randomized Controll Trial
Start date
2018-04-20
Primary completion
2018-06-20
Enrollment
400

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.